NovaBone Products commenced U.S. launch of a new syringe for targeted delivery of its 45S5 bioactive glass putty device for the foot and ankle market. The newly launched syringe comes in both a 2.5cc and a 5cc formulation.
NovaBone Putty bone graft substitute, cleared by FDA in 2006, closely mimics the mineral composition of natural bone. NovaBone is designed to provide an ideal environment for new bone formation, facilitating the integration of graft material and host tissue.
Sean Finnerty, Executive Vice President of Sales and Marketing at NovaBone, said, “This is NovaBone’s first product specifically designed for the foot and ankle market. Along with our NovaForm Wound Matrix clearance earlier this year, this shows our commitment to diversifying our portfolio, leveraging our Bioactive Glass manufacturing expertise, and providing surgeons in multiple specialties with solutions best suited for their patients.”
NovaBone Products commenced U.S. launch of a new syringe for targeted delivery of its 45S5 bioactive glass putty device for the foot and ankle market. The newly launched syringe comes in both a 2.5cc and a 5cc formulation.
NovaBone Putty bone graft substitute, cleared by FDA in 2006, closely mimics the mineral composition of natural bone....
NovaBone Products commenced U.S. launch of a new syringe for targeted delivery of its 45S5 bioactive glass putty device for the foot and ankle market. The newly launched syringe comes in both a 2.5cc and a 5cc formulation.
NovaBone Putty bone graft substitute, cleared by FDA in 2006, closely mimics the mineral composition of natural bone. NovaBone is designed to provide an ideal environment for new bone formation, facilitating the integration of graft material and host tissue.
Sean Finnerty, Executive Vice President of Sales and Marketing at NovaBone, said, “This is NovaBone’s first product specifically designed for the foot and ankle market. Along with our NovaForm Wound Matrix clearance earlier this year, this shows our commitment to diversifying our portfolio, leveraging our Bioactive Glass manufacturing expertise, and providing surgeons in multiple specialties with solutions best suited for their patients.”
Copy to clipboard 
